The global inhalation formulation market is poised for steady expansion over the coming decade, driven by technological advancements in drug delivery systems and the rising prevalence of chronic respiratory conditions. According to market forecasts, the sector will grow at a compound annual growth rate (CAGR) of 5.7% between 2024 and 2034. This translates into an increase in market value from...